Back to search

Poland· PL-100194515

Levofolic 50 mg/ml roztwór do wstrzykiwań / do infuzji

A detoxifying agents for antineoplastic treatment product containing acidum levofolinicum, registered in Poland by medac Gesellschaft fuer klinische Spezialpraeparate mbH. The same ATC class is registered in 3 of our 19 countries.

ATC V03AF

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedLevofolic 50 mg/ml roztwór do wstrzyk…ATCV03AFREGISTER NO.PL-100194515PACKS LISTED6CHECKEDSeptember 27, 2026

Where it is registered

Acidum levofolinicum is registered in 3 of 19 countries.

Countries holding a registration under ATC V03AF (detoxifying agents for antineoplastic treatment), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 2 of them publish a price we can compare per daily dose

Acidum levofolinicum · ATC V03AF

3 / 19 countries

  • Denmark
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Acidum levofolinicum
Manufacturer
medac Gesellschaft fuer klinische Spezialpraeparate mbH
Country
Poland (PL)
ATC code
V03AF
ATC class
Detoxifying agents for antineoplastic treatment
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 6

  • gtin
    05909990648801
  • gtin
    05909990648849
  • gtin
    05909990648856
  • gtin
    05909990648818
  • gtin
    05909990648825
  • gtin
    05909990648832

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Acidum levofolinicum in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All acidum levofolinicum products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

  • Austria · Voxsio
  • Belgium · Elvorine, Levofolic
  • Germany · Levofolic, Voxsio
  • Estonia · Levofolinic Acid Medac
  • Spain · Isovorin
  • Finland · Levofolic
  • France · Elvorine, Levofolinate De Calcium Zentiva
  • United Kingdom (Northern Ireland) · Levofolinic Acid Medac
  • Greece · Folivoran
  • Italy · Calcio Levofolinato Teva Generics, Folanemin
  • Lithuania · Levofolino Rugštis Medac
  • Luxembourg · Elvorine
  • Latvia · Levofolic
  • Portugal · Levofolic, Levofolinato De Cálcio Farmoz
  • Sweden · Natriumlevofolinat Medac
  • Slovenia · Levofolic
  • Slovakia · Levofolic

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/529db5e9-c1dc-4462-998f-46146049c89c
GET /v1/drugs/529db5e9-c1dc-4462-998f-46146049c89c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór do wstrzykiwań / do infuzji",
  "source": "urpl",
  "strength": "50 mg/ml",
  "packaging": "05909990648801 ¦ Rp ¦ 43768\n1 fiol. 1 ml\n05909990648818 ¦ Rp ¦ 43769\n1 fiol. 4 ml\n05909990648825 ¦ Rp ¦ 43770\n1 fiol. 9 ml\n05909990648832 ¦ Rp ¦ 43771\n5 fiol. 1 ml\n05909990648849 ¦ Rp ¦ 43772\n5 fiol. 4 ml\n05909990648856 ¦ Rp ¦ 43773\n5 fiol. 9 ml",
  "substance": "Acidum levofolinicum 50 mg/ml",
  "common_name": "Acidum levofolinicum",
  "pl_product_id": "100194515",
  "pozwolenie_nr": "14626",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

See everything about acidum levofolinicum.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.